Compounded Tirzepatide Therapy for Weight Loss: A Health Economics & Outcomes Research (HEOR) Analysis.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Compounded Tirzepatide Therapy for Weight Loss: A Health Economics & Outcomes Research (HEOR) Analysis.
- Published In:
- International journal of pharmaceutical compounding, 29(1), 52-63 (2025)
- Authors:
- Guth, Michael As
- Database ID:
- RPEP-11235
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11235APA
Guth, Michael As. (2025). Compounded Tirzepatide Therapy for Weight Loss: A Health Economics & Outcomes Research (HEOR) Analysis.. International journal of pharmaceutical compounding, 29(1), 52-63.
MLA
Guth, Michael As. "Compounded Tirzepatide Therapy for Weight Loss: A Health Economics & Outcomes Research (HEOR) Analysis.." International journal of pharmaceutical compounding, 2025.
RethinkPeptides
RethinkPeptides Research Database. "Compounded Tirzepatide Therapy for Weight Loss: A Health Eco..." RPEP-11235. Retrieved from https://rethinkpeptides.com/research/guth-2025-compounded-tirzepatide-therapy-for
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.